Our study has successfully developed and validated a novel model for predicting the occurrence of anemia following chemotherapy in osteosarcoma patients, integrating ALB, Ca, CREA, D‐dimer, and ESR as predictive variables. The gene discussed is ALB; the disease is osteosarcoma.